Summary
Bone marrow trephines from 31 patients with an initial diagnosis of myelodysplastic syndromes (MDS) were examined and analyzed histologically and immunohistochemically. In those cases terminating in overt leukemia (6/31, 19%), the number of bone marrow mast cells was significantly reduced, compared with those which did not evolve to overt leukemia. The bone marrow lymphoid cells that may participate in immunosurveillance against the proliferation of blast cells were also significantly reduced in cases terminating in overt leukemia. However, S-100 protein-positive cells, which include histiocytes and suppressor T-cells, were increased in cases terminating in overt leukemia. The results indicated that examination of the bone marrow to determine the proportions of mast cells and lymphoid cells which may be involved in host defense systems may be useful in predicting the evolution to overt leukemia in MDS. In the present series, patients with a hypocellular marrow (5/31, 16%) did not progress to overt leukemia and had a significantly lower bone marrow reticulin content, a significantly lower megakaryocyte count, a relatively higher mast cell count and a significantly higher lymphoid cell count than those with a normocellular or hypercellular marrow. These findings may reflect the initial features of MDS or, possibly, that hypocellular MDS is an independent entity with a low potential for biastic proliferation.
Similar content being viewed by others
References
Anderson RL, Bagby GC (1982) The prognostic value of chromosomal studies in patients with the primary preleukemia syndrome (hemopoietic dysplasia). Leuk Res 6:175–181
Ascensas JL, Kay NE, Wright JJ, Arthur D, Finkel B, Rydell R, Kaplan ME (1986) Lymphoblastic transformation of myelodysplastic syndrome. Am J Hematol 22:431–434
Barton JC, Conrad ME, Parmley RT (1980) Acute lymphoblastic leukemia in idiopathic sideroblastic anemia: evidence for a common lymphoid and myeloid progenitor cell. Am J Hematol 9:109–115
Bauermeister DE (1971) Quantitation of bone marrow reticulin-a normal range. Am J Clin Pathol 56:24–31
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189–199
Brito-Babapulle F, Catovsky D, Galton DAG (1987) Clinical and laboratory features ofde novo acute myeloid leukaemia with trilineage myelodysplasia. Br J Haematol 66:445–450
Bynoe AG, Scott CS, Ford P, Roberts BE (1983) Decreased T helper cells in the myelodysplastic syndromes. Br J Haematol 54:97–102
Chiao JW, Freitag WF, Steinmetz JC, Andreff M (1981) Changes of cellular markers during differentiation of HL-60 promyelocytes to macrophage as induced by T-lymphocyte conditioned medium. Leuk Res 5:477–490
Clark R, Peters S, Hoy T, Smith S, Whittaker K, Jacobs A (1986) Prognostic significance of hypoploid haematopoietic precursors in myelodysplastic syndromes. N Engl J Med 314:1472–1475
Cline MJ, Golde DW (1979) Cellular interactions in haematopoiesis. Nature 277:177–181
Delacretaz F, Schmidt P-M, Piguet D, Bachmann F, Costa J (1987) The FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 87:180–186
Dörmer P, Hershko C, Wilmanns W (1987) Mechanisms and prognostic value of cell kinetics in the myelodysplastic syndromes. Br J Haematol 67:147–152
Fenaux P, Jouet JP, Zandecki M, Lai JL, Simon M, Pollet JP, Bauters F (1987) Chronic and subacute myelomonocytic leukaemia in the adult: a report of 60 cases with special reference to prognostic factors. Br J Haematol 65:101–106
Fohlmeister I, Fischer R, Mödder B, Rister M, Schaefer H-E (1985 a) Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol 38:1218–1224
Fohlmeister I, Fischer R, Schaefer H-E (1985b) Preleukemic myelodysplastic syndromes (MDS): Pathogenetical considerations based on retrospective clinicomorphological sequential studies. Anticancer Res 5:179–188
Fohlmeister I, Reber T, Fisher R (1985 c) Bone marrow mast cell reaction in preleukemic myelodysplasia and in aplastic anemia. Virchows Arch [Pathol Anat] 405:503–509
Foucar K, Langdon RM, Armitage JO, Olson DB, Carroll TJ (1984) Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer 56:553–561
Frisch B, Bartl R (1986) Bone marrow histology in myelodysplastic syndromes. Scand J Haematol [Suppl] 45:21–37
Goordyal P, Isaacson PG (1985) Immunocytochemical characterization of monocyte colonies of human bone marrow: a clue to the origin of Langerhans cells and interdigitating reticulum cells. J Pathol 146:189–195
Hall PA, Lindeman R, Butler MG, Amess JAL, D’ardenne AJ (1987) Demonstration of lymphoid antigens in decalcified bone marrow trephines. J Clin Pathol 40:870–873
Hamaguchi Y, Kanakura Y, Fujita J (1987) Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue type mast cells. J Exp Med 165:268–273
Hokland P, Kerndrup G, Griffin JD, Ellegaard J (1986) Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood 67:898–902
Hsu S-M, Reine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577–580
Hussein KK, Salem Z, Bottmley SS, Livingstone RB (1982) Acute leukemia in idiopathic sideroblastic anemia: response to combination chemotherapy. Blood 59:652–656
Jacobs A (1986) Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications. J Clin Pathol 38:1201–1217
Jacobs A (1987) Human preleukemia: Do we have a model? Br J Cancer 55:1–5
Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD (1986) Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 67:1765–1772
Kitagawa M, Matsubara O, Kasuga T (1986) Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia. Cancer Res 46:3034–3039
Knox SJ, Greenberg BR, Anderson RW, Rosenblatt LS (1983) Studies of T-lymphocytes in preleukemic disorders and acute nonlymphocytic leukemia: In vitro radiosensitivity, mitogenic responsiveness, colony formation, and enumeration of lymphocytic subpopulations. Blood 61:449–455
Nagler A, Hazani A, Etzioni A, Tatarsky I (1988) Distribution of T lymphocyte subsets preceding refractory anemia with excess blasts in transformation in a child. Acta Haematol 79:103–106
Peters SW, Clark RE, Hoy TG, Jacobs A (1986) DNA content and cell cycle analysis of bone marrow cells in myelodysplastic syndromes (MDS). Br J Haematol 62:239–245
Poppema S, Hollema H, Visser L, Vos H (1987) Monoclonal antibodies (MT1, MT2, MB1, MB2, MB3) reactive with leukocyte subsets in paraffin-embedded tissue sections. Am J Pathol 127:418–429
Prokocimer M, Polliack A (1981) Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol 75:34–38
Raskind WH, Tirumali N, Jacobson R, Singer J, Failkow PJ (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 63:1318–1323
Ribera J-M, Cervantes F, Rozman C (1987) A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria. Br J Haematol 65:307–311
Roche WR (1986) The nature and significance of tumour-associated mast cells. J Pathol 148:175–182
Sansoni P, Rowden G, Manara GC, Ferrari C, Panfilis GD (1987) S-100-positive T cells are largely restricted to a CD8positive, 9.3-negative subset. Virchows Arch [Cell Pathol] 53:301–307
Todd WM, Pierre RV (1986) Preleukaemia: A long-term prospective study of 326 patients. Scand J Haematol [Suppl] 45:114–120
Tricot G, Wolf-Peters CD, Hendrickx B, Verwilghen RL (1984a) Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol 57:423–430
Tricot G, Wolf-Peters CD, Vlietinck R, Verwilghen RL (1984b) Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol 58:217–225
Tricot G, Boogaerts MA, Wolf-Peters CD, Van den Berghe H, Verwilghen RL (1985) The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br J Haematol 59:659–670
Vallespi T, Torrabadella M, Julia A, Irriguible D, Jaen A, Acebedo G, Triginer J (1985) Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Br J Haematol 61:83–92
Vanstapel MJ, Peeters B, Cordeil J, Heyne W, Wolf-Peters DC, Desmet V, Mason DY (1985) Production of monoclonal antibodies directed against antigenic determinants common to the end chain of bovine brain S-100 protein. Lab Invest 52:232–238
Yoo D, Lessin LS, Jensen WN (1978) Bone marrow mast cells in lymphoproliferative disorders. Ann Intern Med 88:753–757
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitagawa, M., Kamiyama, R., Takemura, T. et al. Bone marrow analysis of the myelodysplastic syndromes: histological and immunohistochemical features related to the evolution of overt leukemia. Virchows Archiv B Cell Pathol 57, 47–53 (1989). https://doi.org/10.1007/BF02899064
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02899064